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Unique laser coding 
A B S T R A C T   
Counterfeiting of the products for healing is as old as trading, and it is difficult to quantify the magnitude of the 
problem. It is known that substandard and/or falsified (SF) medicines are a growing global threat to health, and 
they cause serious social and economic damage. The EU has a strong legal framework for medicines, it is 
mandatory to meet the requirements of Directive 2011/62/EU. Serialisation prevents SF medicinal products from 
entering the legal distribution chain. The present study is an extension of the original idea and aims to develop a 
laser technology-based method to mark an individual traceable code on the surface of the tablet, which tech-
nology can also be used for marking personalized medicines. The method is based on the ablation of the upper 
layer of a double-layer, differently coloured coating. The 2D code should be formed without harming the 
functional layer, and anyone with a smartphone integrated with a camera should be able to authenticate these 
drugs with a suitable application. The present findings confirmed that KrF excimer laser and Ti:sapphire 
femtosecond laser are efficient and reliable for marking. These should be promising candidates for pharma-
ceutical companies that would like to have additional protection against drug counterfeiters.   
1. Introduction 
Counterfeiting of the products for healing is as old as trading, dating 
back to 1495 BCE, when there was a hunt for genuine medicinal plants at 
the request of Queen Hatshepsut of Egypt because the market was full of 
worthless fakes (Brickell, 2001). In the 18th century, when malaria was 
still endemic in Europe, the continent was flooded with false cinchona 
bark used to treat fevers (WHO, 2017a). 
Substandard and falsified (SF) medicinal products pose a growing 
threat to public health as they can deliver hazardous treatment or even 
cause death (Han et al., 2012a). Moreover, in health institutions phy-
sicians and pharmacists may not even be aware of patients buying 
medicines from uncertain or illegal sources, but these products are likely 
to influence the success of therapies (Fittler et al., 2018b). Bringing these 
drugs under control is a considerable challenge globally (Han et al., 
2012a). 
Substandard medicines are authorized medical products that fail to 
meet either their quality standards or specifications, or both, while 
falsified medical products are those that deliberately misrepresent their 
identity, composition or source (WHO, 2017b). 
Some falsified medical products are almost visually identical to the 
genuine product and very difficult to detect. However, many can be 
identified (WHO, 2018). Possible techniques for detection: visual 
analysis (inspection of packaging condition, labelling, spelling mis-
takes, dosage units, expiry dates, or various product security features 
like watermarks, holograms or microprinting, etc.), physical analysis 
(observation of discolourations, surface investigations by microscopy, 
furthermore, evaluation of disintegration or dissolution measurements, 
etc.), and chemical analysis (classical chemistry or instrumental 
analysis such as spectroscopy, spectrometry, chromatography, etc.) 
(Davison, 2011; Roth et al., 2019). 
The EU has a strong legal framework for medicines. At the end of the 
distribution chain, only licensed pharmacies and approved retailers are 
allowed to sell medicines, including legitimate sale via the Internet 
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(European Medicines Agency, 2018a). For EU Member States, since 
February 2019, it has been mandatory to satisfy the requirements of 
Commission Delegated Regulation (EU) 2016/161(European Commis-
sion, 2015) and Directive 2011/62/EU (The European Parlament and 
the Council of the European Union, 2011) of June 2011. Serialisation 
prevents SF medicinal products from entering the legal distribution 
chain. It involves tracing an individual product from the manufacturer 
through the wholesaler to the patient, by a unique 2D identification that 
is put on each box of prescription drugs. The 2D code should include the 
product code, the batch number, the serial number, the expiry date, and 
the national identification number if required by the Member State 
where the product is placed on the market (European Commission, 
2015). In order to combat drug counterfeiting, pharmaceutical manu-
facturers and suppliers are working on adopting a worldwide stan-
dardized identification system (Trenfield et al., 2019). 
The aim of this research is to support the regulation and to develop a 
technology for marking an individual traceable code directly on the 
surface of the medicine. Oral drug delivery is the most preferred and 
convenient route of drug administration (Viswanathan et al., 2017), and 
from among these, tablets are the most chosen pharmaceutical drug 
delivery systems. They are physically and chemically stable during 
storage, simple-to-use, have sustainable production and generally 
excellent content uniformity (Haaser et al., 2013). Therefore, tablets 
were chosen for marking in this study. The laser coding technology al-
lows the authentication of tablets and avoids illegal repackaging. 
For encoding, the Quick Response (QR) Code was chosen, which 
contains information in vertical and horizontal directions. It offers high- 
capacity encoding so it can hold a great volume of information. QR codes 
have different features and data capacities. Some have a maximum 
storing capacity of approximately 7000 figures (Denso Wave, 1994). 
They have an error correction capability that can restore data from a 
partially damaged code, and they offer omnidirectional reading. 
Because of these features, the QR code is suitable for encoding a high- 
level authentication capability (Han et al., 2012b). In the case of tab-
lets, it is possible to encode in the QR code the name of the drug or in-
formation relevant to the patient, the usage, the dose, the ID of the 
producer and the batch number or the expiration date, etc. (Edinger 
et al., 2018). Further research is needed to determine the maximum 
information density of QR codes produced by the laser ablation tech-
nique on curved drug surfaces. In 2018, the European Medicines Agency 
(EMA) published a guideline on the use of mobile scanning and other 
technologies, such as QR coding in labelling and packaging of medicines 
(European Medicines Agency, 2018b). 
If marking of individual tablets is aimed at or necessary, the 
following cases should be considered when laser coding is applied: if the 
tablets to be marked do not have a coating, at least one coloured layer 
should be applied to the drug so that the laser coding process can be 
performed on the surface. In cases when tablets have a coloured coating 
(for example, for improved swallowability or identification purposes), 
that layer could be marked. When a functional coating is needed because 
of the therapy, an extra coating is required on top of it to enable marking 
without the loss of coating functionality. 
In our previous study, the results demonstrated that marking func-
tional coatings by ArF 193 nm excimer laser caused no structural 
damage in the treated films (Ludasi et al., 2018), although titanium 
dioxide particles remained in the film during ablation. Those white 
particles made the accurate reading of the QR codes difficult due to the 
reduced contrast. To eliminate the problem, naturally coloured coatings 
were used (Ludasi et al., 2019). That solution seemed to work, but since 
most coatings contain titanium dioxide for better coverage and/or 
improved photostability, it would greatly restrict the use of this method. 
So, another solution had to be found. Each material has an ablation 
threshold, and for successful marking, the threshold value of the mate-
rial has to be exceeded (Kannatey-Asibu, 2009). The ablation threshold 
of a substance is determined by several parameters, which are mostly 
related to the laser beam. These include the repetition rate of the laser 
(Hz), wavelength, pulse energy and duration, energy density and the 
absorption properties of the substrate. By selecting the proper laser 
parameters, the desired ablation depth can be achieved (Elliott, 1995). 
To solve the difficulty with titanium dioxide, other types of lasers were 
tested in this study. In the first case, a KrF excimer laser with a higher 
wavelength (248 nm) (hereinafter: UV248) was chosen, as it was known 
from previous experience that the excimer laser was safe. Also, the laser 
exceeded the ablation threshold of titanium dioxide at the wavelength of 
248 nm known from the literature (Van Overschelde et al., 2006). In the 
second case, a near-infrared (800 nm), short pulse femtosecond laser 
was used. The assumption was if the pulse is ultrashort, the heat effect is 
negligible, and no or just little chemical or thermal damage occurs 
during the removal of the material. In addition, it can create very fine 
structures, it is more accurately adjustable, faster and also cleaner (Steen 
and Mazumder, 2010). 
In the present experiment, tablets (white) were coated with 2 layers 
of differently coloured coatings. The transparent bottom layer was the 
functional one, while the red-coloured top layer was applied to enable 
marking. The 2D codes were drawn by ablating specific parts of the 
upper coating layer. Anyone with a camera-enabled phone and a suit-
able application should be able to authenticate these drugs. In addition, 
as for healthcare it is increasingly important that each patient receive 
personalized drug therapy instead of a ‘one-size-fits-all’ treatment 
(Ayyoubi et al., 2021), these codes could be used as a label in person-
alized medicine. 
We would like to emphasize that, in addition to all kinds of protec-
tion and coding, the most important strategy that can be adopted for the 
patients’ safety is to organize communication and education campaigns 
to inform them and to educate the public on the safe use of Internet 
pharmacies. People must be taught to be able to differentiate between 
legal and illegal medication suppliers (Fittler et al., 2018a). Mobile 
phone applications that recognize information encoded on tablets can 
dramatically reduce the time for education, especially for the upcoming 
generation. 
2. Materials 
2.1. Tablet core and coating materials 
The active ingredient of the model tablet was Ibuprofen DC 85 (Ibu, 
BASF, Germany) 16.66% (w/w), and excipients: microcrystalline cel-
lulose (Vivapur 102, JRS Pharma, Germany) 74.33% (w/w), crospovi-
done (Kollidon CL-M, BASF, Germany) 5% (w/w), talc (Molar 
Chemicals, Hungary) 3% (w/w) and magnesium-stearate (Molar 
Chemicals, Hungary) 1% (w/w) were used as received. 
The shape of the tablets was as follows: Nr1 type: round with flat 
surface and no break line on it (diameter: 12 mm, crown height: 4.1 mm, 
average weight: 600 mg). Nr 2 type: round with flat surface and no break 
line on it (diameter: 10 mm, crown height: 3.1 mm, average weight: 300 
mg). Nr 3 type: round with flat surface and no break line on it (diameter: 
10 mm, crown height: 4.8 mm, average weight: 500 mg). 
Placebo tablets were also used as coating aid for reasons of saving 
time and material. The placebo tablets were round with biconvex sur-
face and had no break line on them (diameter: 10 mm, crown height: 4.2 
mm, average weight: 350 mg). 
The first (functional) film-forming agent was an aqueous-based 
enteric coating dispersion: Eudragit L30 D55® (Evonik Nutrition & 
Care, Germany). The second film-forming substance was a hydrox-
ypropyl–methylcellulose (HPMC)-based coating formula, Sepifilm PW 
Red (Seppic S.A., France). 
3. Methods 
The ingredients of the tablet were homogenized with a Turbula 
mixer (Willy A. Bachofen Maschienenfabrik, Switzerland) for 8 min, and 
2 min after the addition of the lubricant. The homogenous powder 
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mixture was compressed with a Korsch EK0 (E. Korsch Maschienenfab-
rik, Germany) single punch eccentric tablet press. 
3.1. Coating procedure 
330 g of placebo tablets and 70 g of API (Active Pharmaceutical 
Ingredient) containing tablets were coated together at the same time in 
order to save material and time. 
Eudragit® L30-D55 aqueous polymer dispersion was prepared. It 
consisted of 16.76% w/w dry substance of a methacrylic acid - ethyl 
acrylate copolymer with a ratio of 1:1 (dispersion 30% w/w) (Evonik 
Nutrition & Care GmbH), PlasAcryl® HTP 20 (Evonik Nutrition & Care 
GmbH) 2.9% w/w dry substance was added to the dispersion as 
plasticizer/anti-tacking agent and distilled water 1 h before coating. 
The aqueous HPMC coating solutions consisted of 20% w/w dry 
substance in the case of Sepifilm™ PW Red coating system. According to 
the supplier′s recommendation, they were dispersed in purified water. 
The total mixing time took 45 min, followed by sieving the dispersion 
through a 0.5 mm sieve. 
Spray coating was performed in a 4 M8 Pancoat (ProCepT, Belgium) 
perforated coating pan. 2 layers of coatings were put on the tablets. The 
first layer was Eudragit L30 D55. A 0.8 mm spray nozzle was used for the 
application of the atomised spray coating solution for 75 min, with an 
atomising air pressure of 1.0 bar, a spray rate of 3 g/min and an air flow 
rate of 0.70 m3/min. The drying and cooling process lasted for 15 min. 
Other coating parameters are shown in Table 1. 
The second layer was the HPMC-based ready-to-use coating formula. 
A 0.8 mm spray nozzle was used for the application of the atomised 
spray coating solution for 45 min in the case of Sepifilm PW coating, 
with an atomising air pressure of 2.0 bars, a spray rate of 2 g/min and an 
air flow rate of 0.70 m3/min. The drying and cooling process lasted for 
15 min. Other coating parameters for the second layer are shown in 
Table 2. 
The final coating thickness was measured with a stereomicroscope 
(Zeiss, Germany). Measurements were performed at a magnification of 
500. After calibration, 4–4 tablets were examined, which were cut in 
half along the middle of the tablet band, and each was measured at 10 
places and averaged. 
3.2. Irradiation of coated tablets 
2 different types of lasers were used for the irradiation of the tablets. 
The experimental setup for the laser processing is outlined in Fig. 1. 
KrF excimer laser (UV248) was used for the UV-regime ablation, a 
twin-tube hybrid dye-excimer laser-system (Szatmári, 1994, Szatmári 
and Schäfer, 1988). The current laser setup produced 60 mJ laser pulses 
with a pulse length of 700 fs. The central part of unfocused 4 cm × 4 cm 
pulses was cut out by an aperture 2 cm in diameter and the remaining 
pulses were attenuated with dielectric coated plates to about 1–2 mJ in 
order to avoid plasma formation in the air. The parameters of irradiation 
using excimer laser were the following: wavelength: 248 nm, energy: 
0.5 mJ, number of impulses: 10, spot size: 100 μm, FWHM: 700 fs, flu-
ence: 6.37 J/cm2. 
Ti:sapphire Femtosecond laser (Femto), operating in the TeWaTi 
laser lab at the University of Szeged (TeWaTi, 2019) provided amplified 
pulses with a repetition rate of 200 Hz and maximum pulse energy of 1 
mJ. An achromatic lens with a focal length of 150 mm focused the beam 
onto the target placed into the focal plane, allowing beam imaging of f/ 
19 (F-number) and processing of the target surface with 135 fs pulses. 
Irradiation of tablets using Femto laser: wavelength: 800 nm, energy: 
0.62 mJ, number of impulses: 20, spot size: 110 μm, FWHM: 135 fs, 
repetition rate: 200 Hz, fluence: 6.52 J/cm2. 
A computer-controlled, movable desktop, a motorized translator was 
created to be able to change the position of the tablet during lasering 
(Fig. 1). The QR code was ablated hole by hole. During UV248 laser 
ablation, the oval-shaped holes in the film followed the shape of the 
beam. It took 1.5–2 h to create such a code with the UV248 laser and 10 
mins with the Femto laser. 
3.3. Surface profilometer 
Veeco, Dektak 8 Advanced Development Profiler® was used for 
profilometry measurements. The tips employed had a radius of curva-
ture ~2.5 μm, and the force applied to the surface during scanning was 
~30 μN. The horizontal resolution was 0.1–0.13 μm, and the vertical 
resolution was 40 Å. Dektak software (Microsoft® Windows XP®: 
interactive data acquisition) and Vision® 32 software (data processing, 
2D and 3D image analysis) were used for data evaluation (Veeco In-
struments Inc., New York, USA). 
3.4. Determination of the ablation threshold 
The characteristics of the ablation holes were examined with a sur-
face profilometer. The laser parameters required for ablation were 
determined from the data obtained using a profilometer according to the 
method described below. 
The ablation threshold indicates the minimal laser energy required to 
remove the material from the substrate (i.e., tablet surface). The 
threshold value is a fundamental parameter for laser fine-tuning. In most 
of the cases, the laser operates close to the threshold but with slightly 
higher energy to avoid unwanted side effects, such as the thermal 
distortion of the material. The final etching depth is controlled by the 
number of laser impulses and not by fluence (Lawrence, 2010). 
As the spatial distribution of fluence was different for the two laser 
types (homogeneous flat top and Gaussian), two different methods were 
applied to determine the corresponding ablation threshold. 
The first method is based on the measured ablation rate (ablation 
depth per number of laser impulses). The ablation rate shows a loga-
rithmic correlation with the applied fluence (impulse total energy per 
unit surface area) close to the threshold. The l = (1/α) ln(F/Fth) loga-
rithmic function was fitted to the measurements by using nonlinear 
least-squares (NLLS) Marquardt-Levenberg algorithm in this case. 
The second method is based on the measured ablation diameter. The 
linearized model log(energy) versus estimated impact surface was used 
in this case to calculate the zero crossing by fitting the linear trend to the 
measurements. 
Fig. 2 summarizes the threshold calculation results for the UV248 
laser. Only the first method was used for threshold estimation in this 
case. Fig. 3 shows the results for the Femto laser, where the second 
method was used for threshold estimation in two measurement sessions. 
Table 1 
Coating parameters of Eudragit L30 D55.  













60  Until 50 3 
Coating 45–55 40–45 30–35 15 
Drying 50 38–40 35–37 3 
Cooling 25 25 25 3  
Table 2 
Coating parameters of Sepifilm films.  













60  Until 50 3 
Coating 55 40–42 35 9 
Drying 40 30 27 3 
Cooling 25 25 25 3  
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3.5. Scanning electron microscope (SEM) 
The ablated tablet was observed by using a scanning electron mi-
croscope (SEM, Hitachi, Japan S4700). The tablets were mounted rigidly 
on a specimen holder with a double-sided carbon adhesive tape and a 
conductive ultrathin golden layer was deployed on them with a sputter 
device (Polaron, UK). The measurements were performed at a magnifi-
cation of 30–5000, applying 10.0 kV electron energy and 1.3–13 MPa air 
pressure. 
3.6. Raman spectra 
Raman spectroscopy was used for the examination of the tablets 
treated by lasers. Spectra were acquired with a Thermo Fisher DXR 
Dispersive Raman spectrometer (Thermo Fisher Scientific Inc., MA, 
USA), a diode laser operating at a wavelength of 780 nm and equipped 
with a CCD camera. Raman measurements were carried out with a laser 
power of 4 mW (Ibu) and 12 mW (Eudragit L30 D55, Sepifilm PW Red) 
at a slit aperture size of 25 µm. The spectra of the tablets treated by lasers 
were collected by using an exposure time of 6 sec, and 10 spectra were 
Fig. 1. Experimental setup for laser processing. The tablet position was adjusted with a motorized XY translator during the QR code engraving. The Z direction 
translator stage was used to set the focus plane precisely on the surface of the tablet. 
Fig. 2. UV248 laser ablation threshold determination. A: Ablation depth estimation based on the number of the applied laser pulses. B: Threshold calculation result 
based on ablation depth by using logarithmic model fit. 
Fig. 3. Femto laser ablation threshold determination. A, B: Threshold calculation result based on ablation diameter using a linearized model. Diagrams A and B 
represent two measurement sets with different pulse energy ranges. 
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averaged in the spectral range of 3200–200 cm− 1 with cosmic ray and 
fluorescence corrections. 
Raman chemical mapping was also performed with the same 
equipment. Spectral data were collected on the surface of the lasered 
tablet, and on the fracture surface of the halved tablet, including the 
treated and the intact region, too. The spectra were determined at 
certain points in a defined area, while the sample had a translational 
motion between each discrete measurement. The point scan system 
measures each spectrum individually at a series of predefined points. 
The chemical map was profiled to the spectra of Eudragit L30 D55 and to 
the spectra of Sepifilm PW Red. In the case of Ibu, profiling was made to 
the peak at 1604 cm− 1 because it was found to be the most typical for the 
API, and it was the most separated from the spectra of the other inves-
tigated components. 
Furthermore, sample analyses were performed on the cross-section 
surface of both types of laser-treated tablets (10 points directly below 
the lasered coated surface and 10 points in the core of the lasered tab-
lets). The mean of these 10 spectra was compared with the mean of the 
10 spectra taken from the core of the untreated tablet and the spectrum 
of Ibu. These averaged spectra were normalized to peak 1604 cm− 1 of 
the Ibu spectrum. 
Data was evaluated with Spectragryph - optical spectroscopy soft-
ware (F. Menges, 2020). 
3.7. In vitro drug disintegration 
In the disintegration studies, the tablets were tested according to the 
standard method of the European Pharmacopoeia with an Erweka model 
ZT71 apparatus (Erweka, Germany). First, 900 ml of artificial enzyme- 
free gastric juice (pH = 1.22) was preheated and maintained at a tem-
perature of 37 ± 0.5 ◦C. According to the guideline, enteric coating 
should be intact for 2 h in acidic media. After 2 h, the medium was 
changed to a phosphate buffered saline solution (pH = 6.82). The time 
necessary for each tablet to disintegrate in acidic and intestinal solution 
was recorded automatically by the apparatus. 
3.8. In vitro drug dissolution 
In the present study, the investigation of drug release kinetics from 
marked tablets was carried out with an Erweka DT 700 (Erweka GmbH, 
Germany) dissolution tester according to the standards of the European 
Pharmacopoeia. A rotating basket method was used for the dissolution 
tests, where the rotation speed was 100 rpm, the dissolution medium 
was 900 ml of artificial enzyme-free gastric juice (pH = 1.22) for 2 h, 
and then it was replaced with 900 ml of phosphate buffered saline so-
lution (pH = 6.82) for 1 h. The pH value was checked with a pH meter. 
The temperature was maintained at 37 ± 0.5 ◦C. As a sample, 5 ml of the 
dissolution medium was taken manually at predetermined intervals 
without being replaced. Medium loss was not taken into account during 
the calculations. Samples were filtered through a 10 μm Poroplast filter 
(Erweka, Germany). The absorbance of ibuprofen DC85 was analyzed at 
222 nm, using a spectrophotometer (Genesys 10S UV–VIS, Thermo 
Fisher Scientific Inc., MA, USA). Four tablets were tested, and samples 
were taken at the following time intervals: at 120 min in the case of 
gastric juice, and after changing to intestinal fluid at 5, 10, 15, 30, 45 
and 60 min. 
4. Results and discussion 
The present study focuses on demonstrating the effectiveness of a QR 
code-based authentication process of film-coated tablets, from the 
formulation of the QR-coded tablets by laser ablation to the decoding 
step using a QR code reader application on a smartphone. 
The primary focus was on removing the titanium dioxide particles 
that remained in the film during previous ablation studies (Ludasi et 
al….) by comparing the effectiveness of two different types of lasers in 
marking. The 2D codes were formed by removing particular parts of the 
upper coloured coating. After marking, a detailed quality analysis was 
made to check if any change occurred in the quality of films or in the API 
during the laser intervention. Also, the disintegration and dissolution of 
the lasered products were investigated to confirm that it was possible to 
mark the tablets with functional coating without damaging them during 
the procedure. 
4.1. Microscopic analysis of the coated surface 
The QR code (Fig. 4A) that was lasered on the tablets was generated 
by the QR code generator library libqrencode. (Fukuchi, 2020). A simple 
code (with content: 12345678) was made as the secondary aim was to 
find out if it was possible to ablate a decodable QR code on the surface of 
the tablet by these lasers. Further research is being done on how much 
information can be encoded in a QR code of a given size to keep the 
decoding accuracy. 
The present study confirmed that titanium dioxide particles did not 
interfere with decoding when coding had been done by UV248 or Femto 
lasers. The QR codes applied on the tablets are readable by a smartphone 
with QR code scanner applications downloaded from the Internet, for 
example, with QRbot (https://qrbot.net/) or with the photo mode of the 
mobile phone. The only requirement is that the application must be able 
to read the “inverse” QR code (Fig. 4B), as in this case the tablet is 
coloured and the ablated part is white, just the opposite of the usual QR 
codes. 
The results of the UV248 laser treatment are seen in Fig. 5. It can be 
observed through visual inspection that the 5 × 5 mm QR code is made 
up of dots. 
It is known that a usable QR code can also be created by not over-
lapping parts, such as dots. The UV248 laser-ablated oval-shaped holes 
in the film were in accordance with the shape of the beam. It was 
possible to make a readable code from oval-shaped holes, too, even in 
cases where laser irradiation was not perfect, as the code has error 
correction capability that can restore the missing data, as seen on the 
ablated QR code that is made up of individual points (Fig. 5B,D). Better 
coverage can be obtained by overlapping the holes, which results in a 
more readable code. Nevertheless, care must be taken not to punch 
through the Eudragit layer. The depth of ablation can be controlled by 
changing the number of pulses on the sample place or the fluence, which 
allows the accurate setting of the penetration depth to the coating layer. 
It took 1.5 and 2 h to create such a code by the UV 248 laser depending 
on whether there was an overlap between the holes or not. Fewer shots 
mean faster but still effective marking. 
The same computer-controlled movable desktop was coupled with 
the Femto laser to mark the tablet, as in the previous case. At this time, 
the shape of the beam was round, thus the ablated holes were too, and 
they overlapped, as shown in Fig. 6. The ablation of the QR code took 
about 10 min, as the most important limiting factor of overall ablation is 
the repetition rate of the laser. Therefore, the higher frequency (200 Hz) 
of the Femto laser dramatically shortens the marking procedure. 
Fig. 7A–C displays the scanning electron micrographs of the 4 × 4 
mm QR code on the tablet treated by the UV248 laser. 
Fig. 7A shows a part of the QR code on the tablet surface, and it is 
Fig. 4. Sample QR code ablated on the tablet. A: The common form of the QR 
code. B: The inverse of the QR code ablated onto the coloured tablet. C: The 
same QR code but made of dots, prepared for laser and desktop control. 
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clearly visible that it is made of overlapping dots, as described above. 
The holes are deeper at the overlapping parts. It can also be seen that the 
surface of the untreated coating is uneven, and the holes visible on the 
untreated surface may have remained from the bubbles formed during 
the coating process due to too quick drying since the air did not have 
time to diffuse out. Fig. 7B displays the lasered tablet surface at greater 
magnification. The holes in the ablated surfaces could also have resulted 
from bubble formation. Fig. 7C shows the cross-section surface of the 
tablet, where the place of lasering is seen in the framed part. The glossy 
part on the top of the tablet is the PW red coating, which is about 5–10 
μm thick. The bottom coating, which is 60–70 μm thick, seems to be 
intact. The ablated surface of the sample has no large damage. Only a 
physical change is observed in the structure as a result of the removal of 
the coating by the UV248 laser, and no obvious sign of chemical change 
is detected. 
Fig. 7D-G displays the micrographs of the Femto lasered tablet. In 
Fig. 7D, a part of a QR code is seen on a halved tablet. The dots which 
compose the QR code are clearly visible. The penetration depth seems to 
be greater with the Femto laser than with the UV248. In Fig. 7E the 
lasered surface is visible at higher magnification, where intact regions 
may be identified between the holes. Fig. 7F shows one hole at higher 
magnification. At the bottom of the ablation cavity a different material is 
detected, which is thought to be the functional coating because of its 
different, more porous structure. The laser penetration here seems to 
have taken place right up to the bottom of the coating. In Fig. 7G, the 
cross-section surface of the halved tablet is seen. The tablet was fixed to 
the holder upside down. The ablation area is visible in the framed part. 
The Femto laser removed the upper coating, which is about 50 μm thick, 
and in some places, the laser also penetrated into the functional Eudragit 
coating. Nevertheless, because its thickness is about 150 μm, function-
ality may still be intact despite its partial absence. 
Similarly to the UV248 laser, it may be seen that the Femto laser did 
not cause considerable damage in the coating structure during the 
treatment, either. Only a physical change may be detected in the ablated 
area, fragments of the coating film are visible where the coating was 
removed. No visible sign of chemical changes was detected in the upper 
or in the bottom layer. Overall, it can be stated that no visible chemical 
change occurred on the treated surface when using either of the two 
lasers. 
4.2. Disintegration test 
In the disintegration studies, six pieces of coated and ablated tablets 
were tested from tablet type Nr 3. The tablets remained intact during the 
Fig. 5. Tablet encoded by UV248 laser. A: The size of the QR code is 4 × 4 mm. B: The size of the QR code is 5 × 5 mm. C: Microscopic picture of the 4 × 4 mm QR 
code. D: Microscopic picture of the 5 × 5 mm QR code. 
Fig. 6. Tablet encoded by Femto laser. A: Visible to the naked eye. B: Microscopic picture.  
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2-hour disintegration process in the artificial enzyme-free gastric juice, 
which corresponds to the result expected according to the European 
Pharmacopoeia, as they had a gastro-resistant coating. After changing to 
the intestinal fluid, the disintegration test was complete in 30 min for all 
tablets. This result confirmed our preliminary conclusion based on SEM 
analysis, according to which the lasering of the upper coating left the 
functional coating in the bottom intact, and it is possible to mark 
functionally coated tablets. 
4.3. In vitro drug dissolution test 
For in vitro drug dissolution tests, tablets of different shapes were 
used: A: Type Nr1, B: Type Nr2, C and D: Type Nr3. Three of the 
investigated tablets remained intact after 120 min in the gastric me-
dium. The amount of the dissolved API was 0.15%, 2.12%, and 0.92%, 
for A, C and D, respectively, while the dissolved API was 35.2% for 
Tablet B, which partially disintegrated during this period. 
In order to save time and material, the differently shaped API con-
taining tablets were coated together with placebo tablets. Presumably, 
due to their different geometry, they were mixed inappropriately during 
coating, therefore they might have different coating thicknesses. Tablet 
coating thickness may also vary in the case of identical tablets, as 
observed by M. Wolfgang et al., where it varied between 56.3 µm and 
86.9 µm (Wolfgang et al., 2019). The literature also confirms that the 
shape of the tablet directly influences intra-tablet coating uniformity. 
The most likely reason for intra-tablet coating variability is the preferred 
orientation of tablets when passing through the spray zone of the coater 
(Wilson and Crossman, 1997). There was another investigation of inter- 
tablet coating layer thickness, where a comparison of both sides of the 
tablet surface was made. It shows that the thickness of the coating layer 
of some tablets on one side of the tablet is up to 10 μm thicker than on 
the other one (Ho et al., 2007). Achieving a high level of intra-tablet 
uniformity is especially important for functional film coatings (Dong 
et al., 2017), where uniform thickness is required to guarantee the 
desired drug release rate to the patient (Sacher et al., 2019). In the 
present study, it can be assumed that in the case of tablet B, the coating 
was thinner and had been damaged during the marking. It is likely that if 
only tablets of the same shape are coated at a time, the layer thickness 
will be more uniform and the inner, functional layer can be protected 
from damage. 
The dissolution profile of the tablets in phosphate buffered saline 
solution is shown in Fig. 8. It can be concluded that during the one-hour 
in vitro studies, the tablets acted in accordance with pharmacopoeial 
standards and the disintegration and dissolution process started. It is 
seen that the dissolution of tablet B started earlier than that of the others, 
and the final concentration was lower. The explanation for this phe-
nomenon is that the dissolution of tablet B had already started in the 
gastric medium. 
4.4. Coating film thickness 
To confirm the assumption that not only the inter-tablet but also the 
intra-tablet variability of final coating thickness is spread over a wide 
range, microscopic film thickness measurement was applied. Fig. 9 
shows the difference in the thickness of the coating on the top and on the 
side of the tablet. Coating thickness averages measured on different 
tablets, determined on the basis of measurements at 10 places of 4–4 half 
tablets, are presented in Table 3. 
4.5. Raman 
Finally, to confirm that the ablation process causes no chemical 
change, a dispersive Raman spectrometer was used to detect possible 
changes in the coated tablets. Chemical mapping was chosen to deter-
mine if there was a laser-induced change in the coating layers or in the 
Fig. 7. SEM micrographs of laser-treated tablets. First row: Films A, B, C treated by UV248 laser. A: Tablet surface at a magnification of 100×. B: Tablet surface at a 
magnification of 500×. C: The tablet’s cross-section surface at a magnification of 1000×. Second row: Tablets D, E, F, G treated by Femto laser. D: Tablet surface at a 
magnification of 30×. E: Tablet surface at a magnification of 500×. F: Ablation hole at a magnification of 5000×. G: The tablet’s cross-section surface at a 
magnification of 100×. C,G: The place of lasering is shown in the framed section. 
Fig. 8. Drug dissolution curves of the 4 coated and lasered tablets.  
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API in the core during marking. The examination was done on the 
surface of the lasered tablet and on the fracture surface of the halved 
tablet. The chemical map was profiled based on the spectra that are 
summarized in Fig. 10. The full spectrum was applied for raw free films 
(Eudragit L30-D55, Sepifilm PW Red) and a single peak (1604 cm− 1) for 
the API Ibuprofen DC85. 
Figs. 11–14 present the data of the obtained chemical maps. Part “A” 
of the figures shows the microscopic mosaic photo of the laser-treated 
region, the chemically mapped area is framed with a blue or a red 
line. The spectra were collected from places marked by blue or red 
points. The other parts of the Figures show chemical maps, where “B”, 
“C” and “D” show the profiling result of the Eudragit, Ibu and PW red 
film, respectively. In these maps, warm colours show a higher concen-
tration of the profiled materials. Profiling of the PW red spectrum was 
performed only for tablet cross-sections. 
The UV 248 nm laser-treated tablet surface is presented in Fig. 11 
and Fig. 12. The results confirm that the PW red upper layer (Fig. 12D) 
was completely ablated in the places that were lasered. Based on 
Fig. 11C, it can be assumed that the laser had reached the API because 
Fig. 9. Uneven thickness of tablet coatings.  
Table 3 
Thickness of the different coatings.   
12 mm diameter 
round flat tablet 
(600 mg) 
10 mm diameter 
round flat tablet 
(300 mg) 
10 mm diameter 
round flat tablet 
(500 mg)  
49.43 ± 9.23 16.19 ± 9.19 88.02 ± 18.98 
PW red 
coating 
63.12 ± 14.72 61.78 ± 14.67 95.42 ± 13.45 
thickness 
(μm) 
59.31 ± 11.82 34.81 ± 11.76 73.26 ± 22.65  
76.75 ± 13.98 45.78 ± 14.56 69.76 ± 16.54  
182.34 ± 22.44 79.62 ± 17.79 155.45 ± 19.57  
Eudragit 
coating 
145.93 ± 29.54 123.65 ± 29.67 98.02 ± 23.77 
thickness 
(μm) 
204.54 ± 17.57 97.43 ± 23.65 136.23 ± 29.76  
163.78 ± 32.23 134.75 ± 36.76 102.43 ± 13.65  
Fig. 10. Raman spectra of film coatings and the API. A: Eudragit L30-D55, B:Sepifilm PW Red, C: API Ibuprofen DC85. Chemical map profiling was performed on 
spectra A, B and a single peak, which is circled on the spectrum C (1604 cm− 1). (For interpretation of the references to colour in this figure legend, the reader is 
referred to the web version of this article.) 
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Fig. 11. Surface of the tablet treated by UV248 laser. A: Microscopic picture of the surface of the lasered tablet. B: Chemical map profiled to Eudragit L30-D55. C: 
Chemical map profiled to Ibu. 
Fig. 12. Fracture surface of a tablet treated by UV248 laser after halving. A: Microscopic picture of the fracture surface of the lasered tablet. B: Chemical map profiled 
to Eudragit L30-D55. C: Chemical map profiled to Ibu peak. D: Chemical map profiled to Sepifilm PW red. (For interpretation of the references to colour in this figure 
legend, the reader is referred to the web version of this article.) 
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Fig. 13. Surface of the tablet treated by Femto laser. A: Microscopic picture of lasered tablet. B: Chemical map profiled to Eudragit L30-D55. C: Chemical map 
profiled to Ibuprofen. 
Fig. 14. Cross-section surface of the Femto laser treated tablet. A: Microscopic picture of the halved tablet, arrow pointing at the missing PW red coating. B: Chemical 
map of the tablet surface profiled to Eudragit L30-D5. C: Chemical map of the tablet surface profiled to Ibuprofen. D: Chemical map of the tablet surface profiled to 
Sepifilm PW red. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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the thickness of the coating was not consistently even, and furthermore 
because the API might have penetrated into the Eudragit coating 
(Fig. 12C). 
Fig. 13 and Fig. 14 display the tablet surface and the cross-section of 
Femto laser-treated tablets, respectively. In Fig. 13B Eudragit is seen in 
the laser-treated areas, while in Fig. 13C the warm colours show the API 
Ibu, which suggests that the coating thickness was not consistently even, 
and the laser might have reached the API or penetrated into the coating 
in this case as well. 
In Fig. 14A the arrow points to the missing PW red coating, and the 
mapping (Fig. 14D) confirms that it was ablated by the laser. The 
profiling shows that the API is mostly in the tablet core (Fig. 14C), but in 
the same picture, the area of the inner coating is green, which means 
that the API partly migrated from the tablet core to the Eudragit film. 
According to the literature, such migration during the coating process 
can happen if the coating is aqueous-based. Migration is enhanced if a 
component is soluble in the coating solution, and it also depends on the 
spray conditions used during the coating operation (Dansereau et al., 
1993; Guo et al., 2002). Ibu is a Biopharmaceutics Classification System 
(BCS) class II drug with low solubility at pH = 1.2 and pH = 4.5 but high 
solubility at pH = 6.8 (Álvarez et al., 2011). 
To determine if there was a laser-induced change in the API, Raman 
measurements were performed on the fracture surface of the tablets 
treated by the two lasers. Sample analyses were made at 10 points 
directly below the lasered coating surface and at 10 points in the core of 
the lasered tablets. As described in the “Methods” section, 10 spectra 
were averaged at each point. The mean of these spectra was compared 
with the average of 10 spectra taken from the core of an untreated tablet 
and with the spectrum of Ibu. These spectra were normalized to peak 
1604 cm− 1 of the Ibu spectrum and are shownin Fig. 15. 
There was no significant difference between the spectra taken from 
the lasered area compared with the spectra taken from the non-lasered 
area. The most characteristic peaks of Ibu are present in all the 
spectra, with no slip visible. The observed peak intensities can be 
attributed to the relative inhomogeneity of the materials in the tablet, 
depending on how rich or poor Ibu was in the studied region. Sampling 
with a small laser spot may also result in different intensities due to the 
inhomogeneous composition of the tablet. It can be stated that no 
chemical structural change was observed after the labelling. Overall, 
despite the fact that, mainly due to the uneven thickness of the coating, 
the laser might occasionally reach the functional coating besides the 
removal of the PW red layer and also that Ibu may penetrate from the 
core of the tablet into the functional coating, no chemical structural 
change was observed in the coatings during labeling. 
5. Conclusions 
During laser ablation, it is important not to cause any change in the 
medicine. Commonly, it is the thermal effect which can cause problems 
in the material’s quality. At the same time, the coating has to be 
removed at specific points. This can be achieved by choosing the right 
laser and setting the optimal parameters. 
It can be concluded that in the experiment, the threshold exceeded 
the ablation threshold of titanium dioxide during lasering, and it was 
sufficient in its removal. Titanium dioxide did not interfere with QR 
code recognition, which was performed with a mobile phone. 
It was found that ablation with UV248 laser and Femto laser did not 
cause a qualitative change in the material during laser marking. The 
UV248 laser is a laser for laboratory use, while Femto lasers are 
commonly used in the industry. However, the higher repetition rate of 
the Femto laser allows faster and more efficient coding, which has key 
importance in the production. Furthermore, the results show that due to 
the high performance in the fs pulse length, the wavelength is no longer 
a critical parameter as it is for ns or longer pulses. The thermal effects are 
negligibly low in the fs region even at high peak powers. The thermal 
effects of laser ablation can be avoided by reducing the wavelength or 
the impulse length based on the current study. 
It is known that the efficient use of this technology requires further 
development in speed. Other high energy near-infrared pulse lasers that 
operate at multi-kHz versions (with a repetition frequency of multi ten- 
kHz and also MHz), could potentially further shorten the ablation time. 
Those devices could even be used for line speed marking in pharma-
ceutical companies. Also, these devices are scalable in energy and they 
are capable of implementing the one-shot technique. Further research is 
needed in this direction by testing new lasers and new techniques. 
In conclusion, we propose a functionally advanced marking by the 
lasers mentioned in this article, highlighting the Femto laser as a solu-
tion for pharmaceutical companies that would like to have additional 
protection against drug counterfeiters or to label personalized medi-
cines, knowing that the technique needs further improvement. 
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